All PharmaTec Content

Bringing you the latest research in digitalisation, automation and data handling through a range of Speaker Interviews, Industry Insights, and Expert Opinions.

Insight Article
Metadata is a crucial aspect of implementing FAIR data principles and practices. Without metadata, you have no view of what is going on with your unstructured data, context as to what the data is or what it is for.
Edited by Oliver Picken |
20 July 2022
Pharma Data
Video Content
Webinar
Digitalisation is the reality for each of us in our private life. In laboratories, it’s still a dream. But why are we dreaming of digitalisation and of connectivity between your instruments and your leading systems when these things are actually at our fingertips? The reason might be obvious: when the right tools to connect all software silos are missing, we can’t be digitalised in reality.
05 July 2022
Pharma Data
Commentary
In this Commentary article, we explore some of the applications of synthetic data generation in the context of healthcare and treatment. Synthetic data can overcome problems surrounding privacy and enable the sharing of important medical information without compromising the privacy of patients.
30 June 2022
Pharma Data
Written Q&A
Data digitisation has led to a market shift in operability, as well as a strong emphasis on trust and a need for broad standardisation. Zisis Kozlakidis, Head of Laboratory Services and Biobanking at the International Agency for Research on Cancer, sat down with us to discuss current and future trends in digital data governance for healthcare, as well as the need for a coordinated data strategy going forward.
Edited by Ben Norris |
28 June 2022
Pharma Data
Discussion Group Report
Our April 2022 discussion group focused on digital therapeutics. Digital therapeutics are software-based products for the prevention, management and treatment of health conditions.
Edited by Oliver Picken |
14 June 2022
Pharma Data
Insight Article
Data is one of the most important assets for a company but multi-omics data analysis is a challenging field.
Edited by Oliver Picken |
27 May 2022
Pharma Data
Discussion Group Report
Digital health is often seen as the 'next big thing' but there are challenges ahead. This month, our discussion group focused on fragmentation, data flow, protection and regulatory approval.
Edited by Oliver Picken |
05 May 2022
Pharma Data
Commentary
This Commentary article revisits the development and implementation of mobile health data, exploring how initiatives such as the NHS track and trace system helped to mitigate the worst of the impact of the Covid-19 pandemic. Here, we consider the applications of mHealth data for present and future pandemic situations.
Edited by Ben Norris |
26 April 2022
Pharma Data
Insight Article
Digital biomarkers are rapidly being adopted to provide quality insights into patient health. David Nobbs, Biomarker Disease Area Lead at Roche and Valentin, Data Analytics Leader at GSK share how their companies are using digital biomarkers.
Edited by Oliver Picken |
25 April 2022
Pharma Data
Commentary
This Commentary piece looks at the means by which the global approval process for new medicines can be sped up through the controlled use of FAIR data. Key areas of focus include the sharing of healthcare data to bring the patient voice within the clinical setting.
Edited by Ben Norris |
28 March 2022
Pharma Data

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login